In the case of the NKbright cells, significantly increased CD155 expression was measured by the CD8+ NKdim subpopulation in EO preeclampsia compared to the CD8+ NKdim cells from healthy conditions (Figure 5E). The gene discussed is CD8A; the disease is preeclampsia.